ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/6/2026

1. HUBS
2. WDC
3. KVYO
4. SNDK
5. APP
6. ZG
7. DASH
8. XYZ
9. DOX
10. PAYC

Go back to ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
ADC TELECOMM (NYSE: ADCT) Delayed: 1.11 +0.04 (3.74%)
Previous Close $1.07    52 Week High $12.76 
Open $1.07    52 Week Low $5.18 
Day High $1.13    P/E 1.42 
Day Low $1.07    EPS $0.78 
Volume 166,892